CN112552365B - Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one - Google Patents

Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one Download PDF

Info

Publication number
CN112552365B
CN112552365B CN202011505085.0A CN202011505085A CN112552365B CN 112552365 B CN112552365 B CN 112552365B CN 202011505085 A CN202011505085 A CN 202011505085A CN 112552365 B CN112552365 B CN 112552365B
Authority
CN
China
Prior art keywords
reaction
hours
stage
reacting
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011505085.0A
Other languages
Chinese (zh)
Other versions
CN112552365A (en
Inventor
王石华
王尧
李朋涛
王彦光
张新
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hebei Guzhirun Technology Co ltd
Lansheng Biotechnology Group Co ltd
Original Assignee
Hebei Guzhirun Technology Co ltd
Hebei Lansheng Biotech Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hebei Guzhirun Technology Co ltd, Hebei Lansheng Biotech Co ltd filed Critical Hebei Guzhirun Technology Co ltd
Priority to CN202011505085.0A priority Critical patent/CN112552365B/en
Publication of CN112552365A publication Critical patent/CN112552365A/en
Application granted granted Critical
Publication of CN112552365B publication Critical patent/CN112552365B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)

Abstract

An improved process for the preparation of a compound of formula (II) wherein the compound is prepared by a reaction which is elevated in three stages by a gradientUnder the condition that the first stage: reacting for 1.5-2.5 h at 100-120 ℃, and the second stage: reacting for 1.5-2.5 h at 120-130 ℃, and the third stage: reacting for 1.5-2.5 h at 150-160 ℃.

Description

Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one
Technical Field
The present invention relates to an improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one.
Background
(22E, 24R) -5α -ergosta-2, 22-dien-6-one is an important intermediate for the preparation of 24-epibrassinolide.
The 24-epibrassinolide belongs to a sterol plant growth regulator, has double effects of promoting plant cell division and delaying, can promote plant root system development, enhance photosynthesis, improve chlorophyll content of crops, promote metabolism of crops and assist good growth of inferior parts of the crops, thereby promoting the growth of the crops.
Disclosure of Invention
When (22E, 24R) -5α -ergosta-2, 22-dien-6-one of formula (II) is prepared from (22E, 24R) -3α -5-cyclo-5α -ergosta-22-en-6-one of formula (I), an isomerized impurity compound of formula (III) is formed.
Figure BDA0002844664180000011
The present invention aims to provide an improved preparation method by which the formation of impurity compounds of formula (III) can be reduced.
In particular, the invention relates to:
(1) An improved process for the preparation of a compound of formula (II) wherein it is prepared by the reaction,
Figure BDA0002844664180000021
the method is characterized in that the reaction is carried out under the condition of three-stage gradient temperature rise, and the first stage is as follows: reacting for 1.5-2.5 h at 100-120 ℃, and the second stage: reacting for 1.5-2.5 h at 120-130 ℃, and the third stage: reacting for 1.5-2.5 h at 150-160 ℃.
(2) The modified production method of (1) above, wherein the reaction time of the first, second and third stages is about 2 hours, respectively.
(3) The improved production process according to the above (1) or (2), wherein the solvent used in the reaction is N, N-dimethylacetamide or N, N-dimethylformamide.
(4) The improved production process according to any one of the above (1) to (3), wherein the cooling time from the completion of the reaction to the cooling of the reaction mixture to 30℃is controlled within 3 hours.
(5) The improved production process according to the above (4), wherein the cooling time is controlled within 2 hours.
Detailed Description
In the present application, "%" means mass% unless otherwise specified.
The reaction scheme in the improved preparation method of the invention is shown above, and various raw materials used in the method are also known substances, and can be prepared by using commercial products or by a known method.
Unlike the conventional constant temperature reaction, the improved method of the present invention adopts a gradient heating mode to carry out the reaction. Specifically, three-stage gradient temperature-rising reaction is implemented in the reaction, and the first stage is: reacting for 1.5-2.5 h at 100-120 ℃, and the second stage: reacting for 1.5-2.5 h at 120-130 ℃, and the third stage: reacting for 1.5-2.5 h at 150-160 ℃.
The reaction time of each of the above steps is 1.5 to 2.5 hours, and the reaction time at the temperature after the temperature is raised to the temperature of each step is not included in the time required for the temperature raising. The time for the above three reactions is preferably about 2 hours each.
By the improved process of the present invention, the content of the above-mentioned isomerically pure compound (III) in the reaction product can be reduced to less than 5%, whereas the content of the above-mentioned isomerically pure compound in the product is approximately above 8% in the case of a isothermal reaction.
The reaction temperature of the above reaction is high, and therefore a high boiling point solvent is required. Suitable solvents include, but are not limited to, N-dimethylacetamide, N-dimethylformamide, and the like.
Further, the inventors of the present application found that the cooling rate of the reaction mixture after completion of the above reaction affects the color of the objective product (22E, 24R) -5α -ergosta-2, 22-dien-6-one, and that the obtained product was earthy yellow when the cooling time was 8 hours or more, and was pale yellow when the cooling time was shortened to about 5 hours, and was off-white when the cooling time was shortened to 3 hours, and was further shortened to within 2 hours.
Thus, the improved process of the present invention preferably further comprises controlling the above cooling time to within 3 hours, more preferably to within 2 hours.
The present invention will be described more specifically with reference to the following examples, but the present invention is not limited to these specific embodiments and examples, and any modifications and alterations within the scope of the gist of the present invention fall within the scope of the present invention.
Examples
EXAMPLE 1 investigation of the reaction temperature
15g of the compound of formula (I) is added into a 10L reaction bottle, 150mL of N, N-dimethylacetamide is added, stirring is carried out, 0.88g of pyridine hydrochloride and 1.65g of lithium bromide are added, the reaction temperature and time are shown in the following table 1, nitrogen protection is carried out in the whole reaction process, after the HPLC monitoring is finished, the temperature is reduced to 25-30 ℃, the reaction product is added into 300mL of water, crystallization is carried out for 2h at 0-5 ℃, filtration is carried out, and drying is carried out at 50-60 ℃, thus obtaining the compound of formula (II). The impurity content was measured by HPLC and the results are shown in table 1.
TABLE 1
Figure BDA0002844664180000041
The HPLC detection conditions were as follows:
instrument: a liquid chromatograph, UV detector;
chromatographic column: ZORBAX BONUS-RP 250mm 4.6mm 5um;
mobile phase: acetonitrile: water=90:10;
wavelength: 196nm; column temperature: 30 ℃; flow rate: 1.3ml/min.
The retention time of the compound of formula (I) was 22.0min, the retention time of the compound of formula (II) was 25.0min, the retention time of impurity 1 was 20.7min, the retention time of the isomer of formula (III) was 28min, and the retention time of impurity 2 was 33.0min.
As can be seen from table 1: when the reaction is carried out at a constant temperature of 130 ℃ or higher, the impurity content of the isomer of the formula (III) in the obtained product is higher and is 8.5% or higher (batch numbers 1 to 5). On the other hand, when the reaction is carried out at a constant temperature at a relatively low temperature, the reaction rate is low and about 30% of the raw materials remain after 24 hours, so that the efficiency requirement (lot 8) in industrial production cannot be satisfied. The impurity content of the isomer of formula (III) in the product obtained by the two-stage heating method of firstly reacting for 2h at 120-130 ℃ and then reacting for 2h at 150-160 ℃ has a tendency to be reduced to about 7 percent (batch No. 6). The three-stage gradient heating reaction mode of firstly reacting for 2 hours at 100-120 ℃ and then reacting for 2 hours at 120-130 ℃ and further reacting for 2 hours at 150-160 ℃ can greatly reduce the impurity content of the isomer of formula (III) in the obtained product to about 4 percent, and meanwhile, the impurity 1 is reduced compared with the constant temperature reaction mode (batch No. 7).
Example 2 investigation of the influence of the Cooling time after the reaction on the color of the product
The procedure of example 1 was followed in the same manner as in run No. 7, and the cooling time to 30℃after the completion of the reaction was controlled as shown in Table 2.
TABLE 2
Lot number Cooling to 30 deg.c after reaction Product color
1 12h Earthy yellow
2 8h Earthy yellow
3 5h Pale yellow
4 3h White-like color
5 2h White color
6 1h White color
As shown in Table 2, the cooling time after the completion of the reaction is controlled within 3 hours, preferably within 2 hours, which is advantageous for the color of the product and also for the improvement of the production efficiency.
Industrial applicability
By the method, the isomer impurity in the preparation of (22E, 24R) -5 alpha-ergosta-2, 22-diene-6-ketone can be reduced, a product with better color can be obtained, and the quality of a downstream product 24-epibrassinolide can be improved.

Claims (4)

1. An improved process for the preparation of a compound of formula (II) wherein it is prepared by the reaction,
Figure FDA0003833837210000011
the method is characterized in that the reaction is carried out under the condition of three-stage gradient temperature rise, and the first stage is as follows: reacting for 1.5-2.5 h at 100-120 ℃, and the second stage: reacting for 1.5-2.5 h at 120-130 ℃, and the third stage: reacting for 1.5-2.5 h at 150-160 ℃;
the cooling time from the completion of the reaction to the cooling of the reaction mixture to 30 ℃ was controlled to be within 3 hours.
2. The improved process of claim 1 wherein the reaction times of the first, second and third stages are each about 2 hours.
3. The improved production process according to claim 1 or 2, wherein the solvent used in the reaction is N, N-dimethylacetamide or N, N-dimethylformamide.
4. The improved production process according to claim 1 or 2, wherein the cooling time is controlled within 2 hours.
CN202011505085.0A 2020-12-18 2020-12-18 Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one Active CN112552365B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011505085.0A CN112552365B (en) 2020-12-18 2020-12-18 Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011505085.0A CN112552365B (en) 2020-12-18 2020-12-18 Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one

Publications (2)

Publication Number Publication Date
CN112552365A CN112552365A (en) 2021-03-26
CN112552365B true CN112552365B (en) 2023-05-19

Family

ID=75063551

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011505085.0A Active CN112552365B (en) 2020-12-18 2020-12-18 Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one

Country Status (1)

Country Link
CN (1) CN112552365B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111004303A (en) * 2019-12-17 2020-04-14 京博农化科技有限公司 Method for synthesizing 24-epibrassinolide

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111004303A (en) * 2019-12-17 2020-04-14 京博农化科技有限公司 Method for synthesizing 24-epibrassinolide

Also Published As

Publication number Publication date
CN112552365A (en) 2021-03-26

Similar Documents

Publication Publication Date Title
CN101367759B (en) Synthesis of high-purity amlodipine besylate
CN106083673B (en) A kind of preparation technology of carbocisteine
CN104356018B (en) A kind of synthesis of acetoacetanilide compounds and crystallization method
CN104447366A (en) Preparation method of high-purity 2-amino-3, 5-dibromobenzaldehyde
CN112552365B (en) Improved process for the preparation of (22E, 24R) -5α -ergosta-2, 22-dien-6-one
CN109867609A (en) A method of preparing Pregabalin raceme
CN107973796B (en) Preparation method of tadalafil isomer
CN112479938B (en) Preparation method of N-cyclohexyl-2-aminoethanesulfonic acid
CN112300102B (en) Synthetic method of furan ammonium salt
CN107298678B (en) Preparation method of bulk drug suvorexant
CN109867606B (en) Preparation process of p-phenylenediamine
CN104119247B (en) A kind of preparation method of 4 chlorine, 2,5 dimethoxy AAA
CN111205189A (en) Method for preparing o-nitrobenzyl bromide by using microchannel reactor
CN109293590A (en) A method of promoting triazine ring product quality
CN110028453B (en) Preparation method of N-nitroiminoimidazolidine
KR101807904B1 (en) Preparation process of (6r)-tetrahydrobiopterin hydrochloride
CN111116507A (en) Synthetic process of indoxacarb
CN107488111B (en) Method for synthesizing propyl gallate by solid acid catalysis
WO2020048343A1 (en) Synthesis method for 6-furfurylaminopurine
CN109467512B (en) Synthetic method of 3, 4-diamino-benzophenone
KR100704641B1 (en) Methods for the preparation of levofloxacin having a high purity
CN111632400B (en) Recrystallization purification method of enamine salt
CN114773282B (en) Preparation method of 3-tert-butyl-6-ethylthio-1, 3, 5-triazine-2, 4 (1H, 3H) -dione
CN111689913B (en) Chloroacetate of 5-chloro-2- (3-chloromethyl-S-triazolyl) benzophenone, and crystal form and preparation method thereof
CN108892641B (en) Preparation method of lappaconitine hydrobromide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address
CP03 Change of name, title or address

Address after: 052260 No.1, Hongsheng Road West, Mayu Village, Mayu Township, Jinzhou City, Shijiazhuang City, Hebei Province

Patentee after: Lansheng Biotechnology Group Co.,Ltd.

Patentee after: Hebei Guzhirun Technology Co.,Ltd.

Address before: 052260 Mayu village, Jinzhou City, Shijiazhuang City, Hebei Province

Patentee before: HEBEI LANSHENG BIOTECH Co.,Ltd.

Patentee before: Hebei Guzhirun Technology Co.,Ltd.